Product Information
INZIRQO 10 MG/ML ORAL SUSP is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $4.4599 per ML under NDC 70954052210. Its NADAC has been published 19 times since Feb 18, 2026.
The High Outlier badge above means this manufacturer's average price in the hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954052210
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
New Drug (NDA)
FDA Application
NDA219141On Market Since
1/30/2025
Pharmacological Classes
Price Statistics
The NADAC for INZIRQO 10 MG/ML ORAL SUSP has been published 19 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4599 per ML |
|---|---|
| All-time high | $4.4605 (Jun 10, 2026) |
| All-time low | $4.4490 (Apr 22, 2026) |
| 52-week high | $4.4605 |
| 52-week low | $4.4490 |
| Median price | $4.4494 |
| Average price | $4.4527 |
| Largest weekly change | +0.3% (May 20, 2026) |
| Weeks tracked | 19 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of INZIRQO 10 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for INZIRQO 10 MG/ML ORAL SUSP, manufactured by ANI Pharmaceuticals, Inc., is $4.4599 per ML (NDC 70954052210), effective Jun 24, 2026.
How has the price of INZIRQO 10 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for INZIRQO 10 MG/ML ORAL SUSP has held within roughly two percent of its current level. It has been tracked across 19 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for INZIRQO 10 MG/ML ORAL SUSP?
Since Feb 18, 2026, the NADAC for INZIRQO 10 MG/ML ORAL SUSP has ranged from a low of $4.4490 (Apr 22, 2026) to a high of $4.4605 (Jun 10, 2026), with a median of $4.4494 per ML.
Are there cheaper alternatives to INZIRQO 10 MG/ML ORAL SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of INZIRQO 10 MG/ML ORAL SUSP, so no direct lower-cost alternative is listed.
Who manufactures INZIRQO 10 MG/ML ORAL SUSP?
INZIRQO 10 MG/ML ORAL SUSP (NDC 70954052210) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification